Lasa Supergeneri

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE670X01014
  • NSEID: LASA
  • BSEID: 540702
INR
5.67
-0.29 (-4.87%)
BSENSE

Mar 30

BSE+NSE Vol: 1.14 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 36.53% vs -19.47% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 189.32% vs 132.85% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 39.37% vs -53.57% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 32.09% vs 43.73% in Mar 2024

Compare Profit and Loss Results of Lasa Supergeneri
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
142.00
67.00
75.00
111.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
142.00
67.00
75.00
111.94%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-1.00
0.00
0.00%
Raw Materials Consumed
108.00
33.00
75.00
227.27%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
6.00
10.00
-4.00
-40.00%
Operating Expenses
0.00
6.00
-6.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
7.00
-7.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
23.00
0.00
23.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
136.00
64.00
72.00
112.50%
Operating Profit (PBDIT) excl Other Income
6.00
2.00
4.00
200.00%
Other Income
5.00
0.00
5.00
0%
Operating Profit (PBDIT)
11.00
2.00
9.00
450.00%
Interest
2.00
0.00
2.00
0%
Profit before Depriciation and Tax
8.00
2.00
6.00
300.00%
Depreciation
12.00
0.00
12.00
0%
Profit Before Taxation & Exceptional Items
-3.00
2.00
-5.00
-250.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-19.00
2.00
-21.00
-1,050.00%
Provision for Tax
-4.00
0.00
-4.00
0%
Profit After Tax
-14.00
1.00
-15.00
-1,500.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-46.00
8.00
-54.00
-675.00%
Profit Available for appropriations
-61.00
10.00
-71.00
-710.00%
Appropriations
-61.00
10.00
-71.00
-710.00%
Equity Dividend (%)
0%
8%
-8.00
Earnings Per Share
-2.95
1.6
-4.55
-284.38%
Profit And Loss - Net Sales
Net Sales 142.45 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 36.53% vs -19.47% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 189.32% vs 132.85% in Mar 2024

Profit And Loss - Interest
Interest 2.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 39.37% vs -53.57% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -14.76 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 32.09% vs 43.73% in Mar 2024